Source: FinanzNachrichten

Mahana: Mahana Therapeutics: Mahana Secures Permanent Reimbursement in Germany for its Cara Care for Irritable Bowel Syndrome (IBS) Digital Therapeutic

Final price determination from the National Association of Statutory Health Insurance Funds (GKV-SV) paves the way for greater patient access. Mahana Therapeutics, a leading provider of prescripti...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Steven Basta's photo - CEO of Mahana

CEO

Steven Basta

CEO Approval Rating

90/100

Read more